Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-10-09Study of GSK2241658A Antigen-Specific Cancer Immunotherapeutic in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2019-10-09Phase 1/2a Study of Double-Immune Suppression Blockade By Combining a CSF1R Inhibitor (PLX3397) With An Anti-PD-1 Antibody (Pembrolizumab) To Treat Advanced Melanoma And Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-10-04Procurement of Central Nervous System and Extracranial Tumor Tissues, Cerebrospinal Fluid, and Blood From Patients With Melanoma Brain Metastases
-
CLINICAL_TRIALS study record update · 2019-10-04Phase Ib Study to Assess Safety and Tolerability of PDR001 in Combination With Panobinostat in Metastatic Melanoma and Non-small Cell Lung Cancer After Failure of Prior Anti PD1 or PD-L1 Therapy
-
CLINICAL_TRIALS study record update · 2019-10-04Multicentric Cohort of Melanoma Patients in Ile de France Area
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-10-01Improving Advanced Cancer Patient-Centered Care by Enabling Goals of Care Discussions
-
CLINICAL_TRIALS study record update · 2019-09-27A Phase I Open-Label, Non-Randomized, Dose-Escalation Study of rSIFN-co in Subjects With Advanced Solid Tumors and With an Expansion Cohort at Recommended Dose (RD) in Subjects With Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma, Hepatocellular Carcinoma or Colon Cancer
-
CLINICAL_TRIALS study record update · 2019-09-27Clinical Activity, Safety and Immunogenic Properties of Cancer Immunotherapeutic GSK2132231A in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2019-09-26A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2019-09-24Evaluation of Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
-
CLINICAL_TRIALS study record update · 2019-09-19A Phase I Dose Finding Study of Oral LTT462 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.
-
CLINICAL_TRIALS study record update · 2019-09-13A Targeted, Family-Focused Intervention for Melanoma Prevention
-
CLINICAL_TRIALS study record update · 2019-09-12ClinicalTrials.gov study NCT03007823
-
CLINICAL_TRIALS study record update · 2019-09-06A Phase 2 Study of Glembatumumab Vedotin, an Anti-gpNMB Antibody-drug Conjugate, as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2019-08-22STM-02: Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing Insulin-like Growth Factor Receptor 1 (IGF-1R)
-
CLINICAL_TRIALS study record update · 2019-08-21An Open-label, Phase II, Multicenter Study of Enhancing Pembrolizumab Responses in Melanoma Through Intratumoral pIL-12 Electroporation
-
CLINICAL_TRIALS study record update · 2019-08-06Retrospective Chart Review Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced (Unresectable or Metastatic) Melanoma in the United Kingdom
-
CLINICAL_TRIALS study record update · 2019-07-31A Phase Ib/II Study to Investigate the Safety and Clinical Activity of APR-246 in Combination With Dabrafenib in Patients With BRAF V600 Mutant Unresectable and/or mEtastatic Cutaneous MElanoma Resistant to Dabrafenib/Trametinib Combination
-
CLINICAL_TRIALS study record update · 2019-07-24A Randomized Phase II/III Trial of SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron) vs. INTRON®A as Adjuvant Therapy for Melanoma
-
CLINICAL_TRIALS study record update · 2019-07-24Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
-
CLINICAL_TRIALS study record update · 2019-07-22STM-01: Phase I EffTox Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) Given in Combination With Selective VEGFR Inhibitor Pazopanib (Votrient) for Therapy of Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-07-17Early Assessment of Response to Dual Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma Using 18F-FLT PET/CT and PET/MR
-
CLINICAL_TRIALS study record update · 2019-07-16Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2019-07-12Low-dose Interleukin-2 and Pembrolizumab Among Patients With Metastatic Melanoma and Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2019-07-12The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma